Skip to main content
Clinical Trials/NCT00898937
NCT00898937
Terminated
Not Applicable

Pilot Study for Analysis of Tumor Gene Expression by DNA Microarray Analysis in Patients Undergoing Breast Cancer Surgery or Core Biopsy Sampling

Georgetown University1 site in 1 country55 target enrollmentSeptember 1999
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Georgetown University
Enrollment
55
Locations
1
Primary Endpoint
Tumor Gene Expression as Assessed by RNA Microarray Analysis
Status
Terminated
Last Updated
8 years ago

Overview

Brief Summary

RATIONALE: Studying samples of breast tissue in the laboratory may help doctors learn more about the genes and proteins found in breast tissue.

PURPOSE: This phase I trial is studying genes and proteins in breast tissue from women undergoing surgery for breast cancer or core biopsy of the breast.

Detailed Description

OBJECTIVES: * Assess tumor gene expression information from women undergoing surgery for breast cancer or core biopsy sampling of the breast. OUTLINE: This is a pilot study. Tumor tissue is collected and analyzed for tumor gene expression by DNA microarray analysis for research studies. PROJECTED ACCRUAL: A total of 100 patients will be accrued for this study.

Registry
clinicaltrials.gov
Start Date
September 1999
End Date
July 2017
Last Updated
8 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Tumor Gene Expression as Assessed by RNA Microarray Analysis

Time Frame: 1 day

Concentration of RNA recovered from breast needle biopsies

Study Sites (1)

Loading locations...

Similar Trials